PARALLEL PATHWAY INTERACTIONS IN IMIPRAMINE METABOLISM IN RATS

被引:23
作者
CHIBA, M [1 ]
FUJITA, S [1 ]
SUZUKI, T [1 ]
机构
[1] CHIBA UNIV,FAC PHARMACEUT SCI,DEPT BIOPHARMACEUT,1-33 YAYOI CHO,CHIBA 260,JAPAN
关键词
D O I
10.1002/jps.2600771109
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
引用
收藏
页码:944 / 947
页数:4
相关论文
共 23 条
[1]  
ABERNETHY DR, 1985, J PHARMACOL EXP THER, V232, P183
[2]  
ASLEY JJ, 1973, RES COMM CHEM PATHOL, V4, P279
[3]  
BAST A, 1980, BIOCH PHARM, V30, P19
[4]  
BICKEL MH, 1968, ARCH INT PHARMACOD T, V173, P433
[5]  
BORONDY P, 1972, Federation Proceedings, V31, P582
[6]   IMIPRAMINE DEMETHYLATION AND HYDROXYLATION - IMPACT OF THE SPARTEINE OXIDATION PHENOTYPE [J].
BROSEN, K ;
OTTON, SV ;
GRAM, LF .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1986, 40 (05) :543-549
[7]   AGE-ASSOCIATED ALTERATION IN IMIPRAMINE METABOLISM IS POSITION SELECTIVE [J].
CHIBA, M ;
FUJITA, S ;
KITANI, K ;
SUZUKI, T .
BIOCHEMICAL PHARMACOLOGY, 1986, 35 (15) :2628-2630
[8]   POSITION SELECTIVE SEX DIFFERENCE IN IMIPRAMINE METABOLISM IN RAT-LIVER MICROSOMES [J].
CHIBA, M ;
NISHIHARA, E ;
FUJITA, S ;
SUZUKI, T .
BIOCHEMICAL PHARMACOLOGY, 1985, 34 (06) :898-900
[9]   THE ROUTE OF ADMINISTRATION OF IMIPRAMINE AS A FACTOR AFFECTING FORMATION OF ITS METABOLITE DESIPRAMINE [J].
DANIEL, W ;
ADAMUS, A ;
MELZACKA, M ;
SZYMURA, J .
JOURNAL OF PHARMACY AND PHARMACOLOGY, 1982, 34 (10) :678-680
[10]  
DINGELL JV, 1964, J PHARMACOL EXP THER, V143, P14